Cochlear’s shares have collapsed after the hearing implants behemoth again downgraded profit guidance by up to $170m on deteriorating global consumer sentiment and the Middle East conflict.
Cuts to Medicaid legislated by Trump’s One Big Beautiful Bill Act have crippled Cochlear’s American business by restricting coverage for hearing implants. The ASX company said it expected underlying ...
The US Food and Drug Administration on Thursday approved the first gene therapy for inherited hearing loss, a one-time treatment that proved to be life-changing for a small number of children in a ...
The Daily Galaxy on MSN
FDA approves first-ever gene therapy for deafness and 80 percent of kids could hear within a year
Travis used to sleep through everything. Then his mother laughed in the car and woke him up, the first time he had ever heard ...
The Commonwealth Bank is set to take the axe to more jobs. The union says employees are still reeling from the previous ...
Samsung has launched beta programs for every minor One UI update in recent years, though they were mostly limited to Galaxy foldable phones. One UI 8.5, based on Android 16 QPR2, changes that ...
WASHINGTON — The U.S. Space Force selected 14 companies to compete for contracts under a new $1.8 billion procurement of satellites and supporting technologies to monitor activity in geosynchronous ...
Healthcare stocks copped a hiding after Cochlear’s brutal sell-off spilled across the sector, with banks also under pressure as the ... Read More The post Closing Bell: Healthcare hammered as Cochlear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results